Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
PLoS ONE（2021）
摘要
[This corrects the article DOI: 10.1371/journal.pone.0245481.].
更多查看译文
关键词
atorvastatin,asian patients,open-label,multi-center,high-risk
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要